Highlights: The safe supply of psychedelic drug products manufactured at a GMP-level is critical in treating serious mental health issues. Minister of Mental Health and Addictions, the Honourable Carolyn Bennett, has publicly stated that safe drug supply is paramount to reducing overdose deaths. Optimi Health is the largest cultivator of natural EU-GMP psilocybin and MDMA in North America.


Previous articleSilo Pharma to Present at the Dawson James Small Cap Growth Conference on October 12
Next articlePT362 – Cory Firth – Psychedelic Storytelling: Transforming Out Loud